World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
113
Citations
48910
World Ranking
4941
National Ranking
2679

Claudine Isaacs publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Claudine Isaacs sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 491 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Claudine Isaacs D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Claudine Isaacs sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 113 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Claudine Isaacs is affiliated with Georgetown University in the United States. Their research primarily focuses on medicine, with substantial contributions to biochemistry, genetics, and molecular biology. The main subfields of study include oncology, cancer research, pulmonary and respiratory medicine, genetics, and radiology, nuclear medicine, and imaging.

Their work covers a range of topics within cancer research, particularly related to breast cancer. The main topics include breast cancer treatment studies, advanced breast cancer therapies, cancer genomics and diagnostics, BRCA gene mutations in cancer, cancer treatment and pharmacology, HER2/EGFR in cancer research, and cancer immunotherapy and biomarkers.

Claudine Isaacs has collaborated frequently with several researchers. Notable co-authors include Laura J. Esserman, Christina Yau, Angela DeMichele, Douglas Yee, and Hope S. Rugo. These collaborations have yielded numerous publications over time.

The scientist has published extensively in several venues, with a strong presence in:

  • Cancer Research
  • Journal of Clinical Oncology
  • UNC Libraries
  • JAMA Oncology
  • Breast Cancer Research and Treatment

Significant recent papers authored include:

  • Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer, 2020, JAMA Oncology
  • Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion, 2021, Nature
  • Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline, 2020, Journal of Clinical Oncology
  • Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial, 2021, Cancer Cell
  • Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer, 2020, JAMA Oncology

Best Publications

  • Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations

    Timothy R. Rebbeck;Henry T. Lynch;Susan L. Neuhausen;Steven A. Narod

  • Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

    Susan M. Domchek;Tara M. Friebel;Christian F. Singer;D. Gareth Evans

  • Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.

    Saundra S. Buys;Edward Partridge;Amanda Black;Christine C. Johnson

  • Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

    Timothy R. Rebbeck;Tara Friebel;Henry T. Lynch;Susan L. Neuhausen

  • Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up

    Gerald L. Andriole;E. David Crawford;Robert L. Grubb;Saundra S. Buys

  • Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy

    Robert E. Schoen;Paul F. Pinsky;Joel L. Weissfeld;Lance A. Yokochi

  • Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation Carriers

    Timothy R. Rebbeck;Albert M. Levin;Andrea Eisen;Carrie Snyder

  • Screening by Chest Radiograph and Lung Cancer Mortality: The Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Trial

    Martin M. Oken;Willam G. Hocking;Paul A. Kvale;Gerald L. Andriole

  • Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

    Nasim Mavaddat;Daniel Barrowdale;Irene L. Andrulis;Susan M. Domchek

  • Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study

    Noah D. Kauff;Susan M. Domchek;Tara M. Friebel;Mark E. Robson

  • Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.

    T S Frank;S A Manley;O I Olopade;S Cummings

  • Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial

    Rita Nanda;Minetta C Liu;Christina Yau;Rebecca Shatsky

  • Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer

    Hope S. Rugo;Olufunmilayo I. Olopade;Angela DeMichele;Christina Yau

  • Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial

    Fabrice André;Ruth O'Regan;Mustafa Ozguroglu;Masakazu Toi

  • Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

    Timothy R. Rebbeck;Tara Friebel;Theresa Wagner;Henry T. Lynch

  • Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control Study

    Andrea Eisen;Jan Lubinski;Jan Klijn;Pal Moller

  • Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

    Timothy R. Rebbeck;Nandita Mitra;Fei Wan;Olga M. Sinilnikova

  • BRCA1 Sequence Analysis in Women at High Risk for Susceptibility Mutations: Risk Factor Analysis and Implications for Genetic Testing

    Donna Shattuck-Eidens;Arnold Oliphant;Melody McClure;Celeste McBride

  • Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study.

    Constance D. Lehman;Claudine Isaacs;Mitchell D. Schnall;Etta D. Pisano

  • Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

    Steven A. Narod;Marie Pierre Dubé;Jan Klijn;Jan Lubinski

Frequent Co-Authors

Judy Garber
Judy Garber Harvard University
Susan M. Domchek
Susan M. Domchek University of Pennsylvania
Susan L. Neuhausen
Susan L. Neuhausen City Of Hope National Medical Center
Olufunmilayo I. Olopade
Olufunmilayo I. Olopade University of Chicago
Fergus J. Couch
Fergus J. Couch Mayo Clinic
Irene L. Andrulis
Irene L. Andrulis University of Toronto
Mary B. Daly
Mary B. Daly Fox Chase Cancer Center
Eitan Friedman
Eitan Friedman City University of New York
Timothy R. Rebbeck
Timothy R. Rebbeck Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related online degrees and alternative career pathways can be valuable for those considering or pursuing Medicine in the USA. For current registered nurses, advancing your credentials is more accessible than ever. You can find the cheapest rn to bsn online programs to help you earn your BSN affordably while working.

If you hold a non-nursing bachelor’s degree and want to transition into nursing, there are entry level msn programs online that streamline your path to an advanced nursing role. These programs are designed for motivated career changers looking for efficient, accredited pathways.

Admission to medical and nursing schools can be highly competitive, but some nursing programs with high acceptance rates do exist, providing more accessible entry points into the field.

For those interested in healthcare careers that don’t require direct patient care, consider administrative roles. Reputable medical billing and coding schools online with financial aid can help jumpstart your journey into this in-demand specialty, with flexible study options and potential financial support.

Best Scientists Citing Claudine Isaacs

Trending Scientists

Recently Published Articles